These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35932320)

  • 1. Comment on "Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double‑blind placebo controlled clinical trial".
    Lao Y; Bai Y; Wang Y; Dong Z
    World J Urol; 2022 Oct; 40(10):2585-2586. PubMed ID: 35932320
    [No Abstract]   [Full Text] [Related]  

  • 2. Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial.
    Tawfik AM; Radwan MH; Abdulmonem M; Abo-Elenen M; Elgamal SA; Aboufarha MO
    World J Urol; 2022 Oct; 40(10):2505-2511. PubMed ID: 35802142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental rodent models of chronic prostatitis: effect of phosphodiesterase 5 inhibitor on chronic pelvic-pain-related behavior].
    Yamaguchi H; Kurita M; Yoshinaga R; Asao Y; Oka M
    Nihon Yakurigaku Zasshi; 2019; 154(5):259-264. PubMed ID: 31735755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
    Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M
    Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia.
    Hiramatsu I; Tsujimura A; Soejima M; Yoshiyama A; Nagashima Y; Ishikawa K; Uesaka Y; Nozaki T; Ogishima T; Shirai M; Mitsuhashi I; Sugimura S; Mizuno T; Noto K; Shigeta Y; Takasu J; Honda S; Iwata S; Horie S
    Int J Urol; 2020 Jan; 27(1):53-57. PubMed ID: 31587411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic pelvic pain and prostate inflammation in rat experimental autoimmune prostatitis: Effect of a single treatment with phosphodiesterase 5 inhibitors on chronic pelvic pain.
    Kurita M; Yamaguchi H; Okamoto K; Kotera T; Oka M
    Prostate; 2018 Nov; 78(15):1157-1165. PubMed ID: 30009466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voiding behavior and chronic pelvic pain in two types of rat nonbacterial prostatitis models: Attenuation of chronic pelvic pain by repeated administration of tadalafil.
    Yamaguchi H; Kurita M; Okamoto K; Kotera T; Oka M
    Prostate; 2019 Apr; 79(5):446-453. PubMed ID: 30549073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tadalafil on chronic pelvic pain and prostatic inflammation in a rat model of experimental autoimmune prostatitis.
    Okamoto K; Kurita M; Yamaguchi H; Numakura Y; Oka M
    Prostate; 2018 Jul; 78(10):707-713. PubMed ID: 29577372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tadalafil Ameliorates Symptoms of Patients with Benign Prostatic Hyperplasia Complicated by Chronic Pelvic Pain Syndrome].
    Nishino Y; Miwa K; Moriyama Y; Fujihiro S; Masue T; Kikuchi M; Nakai C; Deguchi T
    Hinyokika Kiyo; 2017 Mar; 63(3):101-105. PubMed ID: 28331166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial Comment from Dr Tanaka to Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia.
    Tanaka T
    Int J Urol; 2020 Jan; 27(1):58-59. PubMed ID: 31602710
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial Comment from Dr Amano to Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia.
    Amano T
    Int J Urol; 2020 Jan; 27(1):58. PubMed ID: 31588586
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
    Zhang K; Liu Y; Yang W; Wang J; Yang J; Zhang G; Bai W; Chen S
    Urology; 2021 Jul; 153():264-269. PubMed ID: 33482135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study.
    Elist J
    Urology; 2006 Jan; 67(1):60-3. PubMed ID: 16413333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study.
    Falahatkar S; Shahab E; Gholamjani Moghaddam K; Kazemnezhad E
    BJU Int; 2015 Oct; 116(4):641-9. PubMed ID: 25307409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
    Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC
    BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.
    Nickel JC; Downey J; Clark J; Casey RW; Pommerville PJ; Barkin J; Steinhoff G; Brock G; Patrick AB; Flax S; Goldfarb B; Palmer BW; Zadra J
    Urology; 2003 Oct; 62(4):614-7. PubMed ID: 14550427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
    Nickel JC; Pontari M; Moon T; Gittelman M; Malek G; Farrington J; Pearson J; Krupa D; Bach M; Drisko J;
    J Urol; 2003 Apr; 169(4):1401-5. PubMed ID: 12629372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC; Narayan P; McKay J; Doyle C
    J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.
    Alexander RB; Propert KJ; Schaeffer AJ; Landis JR; Nickel JC; O'Leary MP; Pontari MA; McNaughton-Collins M; Shoskes DA; Comiter CV; Datta NS; Fowler JE; Nadler RB; Zeitlin SI; Knauss JS; Wang Y; Kusek JW; Nyberg LM; Litwin MS;
    Ann Intern Med; 2004 Oct; 141(8):581-9. PubMed ID: 15492337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.